Display options
Share it on

Evid Based Complement Alternat Med. 2012;2012:371273. doi: 10.1155/2012/371273. Epub 2012 Nov 11.

Balanophora spicata and Lupeol Acetate Possess Antinociceptive and Anti-Inflammatory Activities In Vivo and In Vitro.

Evidence-based complementary and alternative medicine : eCAM

Yuh-Fung Chen, Chien Ching, Tian-Shung Wu, Chi-Rei Wu, Wen-Tsong Hsieh, Huei-Yann Tsai

Affiliations

  1. Department of Pharmacology, China Medical University, No. 91 Hsueh-Shih Road, Taichung 40402, Taiwan ; Department of Pharmacy, China Medical University Hospital, Taichung 40427, Taiwan.

PMID: 23243439 PMCID: PMC3518255 DOI: 10.1155/2012/371273

Abstract

Aims of the present study were to investigate effects of Balanophora spicata (BS) on antinociception and anti-inflammation both in vivo and in vitro. Crude extract of BS inhibited vascular permeability induced by histamine, serotonin, bradykinin, and PGE(2), but not by PAF. Furthermore, BS crude extract, different layers (n-hexane, ethyl acetate, n-butanol, and water layer), and lupeol acetate had significant antinociceptive and anti-inflammatory effects on acetic acid-induced abdominal writhing response, formalin-induced licking behavior, carrageenan-, and serotonin-induced paw edema. The n-hexane layer had the most effective potency among all layers (IC50: 67.33 mg/kg on writhing response; IC50s: 34.2 mg/kg and 21.29 mg/kg on the early phase and late phase of formalin test, resp.). Additionally, lupeol acetate which was isolated from the n-hexane layer of BS effectively inhibited the acetic acid-induced writhing response (IC50: 28.32 mg/kg), formalin-induced licking behavior (IC50: 20.95 mg/kg), NO production (IC50: 4.102 μM), iNOS expression (IC50: 5.35 μM), and COX2 expression (IC50: 5.13 μM) in LPS-stimulated RAW 264.7 cells. In conclusion, BS has antinociceptive and anti-inflammatory effects which may be partially due to the inhibition of changes in vascular permeability induced by histamine, serotonin, bradykinin, and PGE(2) and the attenuation of iNOS and COX-2 expression.

References

  1. J Exp Med. 1993 Aug 1;178(2):749-54 - PubMed
  2. Chem Biodivers. 2009 Jun;6(6):875-80 - PubMed
  3. Eur J Pharmacol. 1986 Jan 14;120(1):33-41 - PubMed
  4. J Ethnopharmacol. 2002 Dec;83(3):177-82 - PubMed
  5. J Ethnopharmacol. 2001 May;75(2-3):267-71 - PubMed
  6. Environ Health Perspect. 1998 Oct;106 Suppl 5:1131-7 - PubMed
  7. Inflammation. 1984 Sep;8(3):223-30 - PubMed
  8. Inflammation. 1977 Mar;2(1):67-82 - PubMed
  9. Molecules. 2010 Dec 23;16(1):1-15 - PubMed
  10. Br J Pharmacol. 1990 Oct;101(2):418-22 - PubMed
  11. J Pharmacol Exp Ther. 1969 Sep;169(1):29-38 - PubMed
  12. Am J Pathol. 1987 Mar;126(3):423-31 - PubMed
  13. Zhongguo Zhong Yao Za Zhi. 2006 Nov;31(21):1798-800 - PubMed
  14. Pain. 1989 Sep;38(3):347-352 - PubMed
  15. Semin Cell Dev Biol. 2013 Jan;24(1):51-7 - PubMed
  16. Eur J Pharmacol. 1996 Feb 22;297(3):257-63 - PubMed
  17. Proc Soc Exp Biol Med. 1962 Dec;111:544-7 - PubMed
  18. J Pharmacol Exp Ther. 2000 Jul;294(1):280-6 - PubMed
  19. J Pharmacol Exp Ther. 1969 Mar;166(1):96-103 - PubMed

Publication Types